Courtagen Life Sciences (Courtagen) has partnered with Certainty Health to improve patient care delivery and reduce health care costs.

Courtagen will implement a cloud-based collaborative ecosystem that will speed up knowledge sharing of critical genotypic to phenotypic correlations, as well as physician-driven treatment data for several neurological diseases.

Certainty Heath is developing mobile precision medicine platform to give physicians and their patients with actionable molecular knowledge on neurological diseases, the diagnostics to identify them, and the treatments available.

The deal grants Courtagen access to Certainty Health’s platform for neurological diseases. The two companies will also work on mapping Courtagen’s clinical data to Certainty Health in compliance with Health Insurance Portability and Accountability Act of 1996 (HIPAA).

According to Courtagen, mapping of clinical data can go beyond physician customer base and can also help pharmaceutical companies in clinical trial preparation or in the discovery of new therapies.

Certainty Health president and COO Chris Yoo said: “We are excited to partner with a truly innovative company, like Courtagen, to address the unmet genetic-information and knowledge needs of physicians in their pursuit to integrate advanced diagnostics into their patient’s health care.

“Courtagen’s rapidly growing database of neurological disease variants, coupled with the associated pathogenicity and phenotype information, is an ideal dataset upon which to build our ecosystem foundation in neurology.”

Courtagen president and COO Brendan McKernan said: “With the explosion of medical research unlocked by the Human Genome Project and next-generation DNA sequencing, we are learning that many diseases like epilepsy, developmental delay, and autism are not single, common diseases, but really collections of diseases, some common, some quite rare.

“It’s impossible for physicians to become experts in all of these rare diseases, and difficult to diagnose without genetic testing due to the overlapping nature of the symptoms, but a collaborative ecosystem, like the one we’re building with Certainty Health, will enable physicians to benefit from the group knowledge of their colleagues around the world and entirety of our test data.”